Evidence map›Paper›PMID 23956972›Full record

SynthesisBioMed research international2013

Probiotics as additives on therapy in allergic airway diseases: a systematic review of benefits and risks.

Rashmi Ranjan Das, Sushree Samiksha Naik, Meenu Singh

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Probiotics in Children with Asthma.Children (Basel, Switzerland) · 2022
    Review
  4. Review
  5. Review
  6. Review
  7. Probiotics in Medicine: A Long Debate.Frontiers in immunology · 2020
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Rashmi Ranjan DasDepartment of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar 751019, India. dr_rashmipgi@yahoo.com
Sushree Samiksha Naik
Meenu Singh
All India Institute of Medical Sciences Bhubaneswar · INPost Graduate Institute of Medical Education and Research · INSriram Chandra Bhanja Medical College Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe conducted a systematic review to find out the role of probiotics in treatment of allergic airway diseases.

methodsA comprehensive search of the major electronic databases was done till March 2013. Trials comparing the effect of probiotics versus placebo were included. A predefined set of outcome measures were assessed. Continuous data were expressed as standardized mean difference with 95% CI. Dichotomous data were expressed as odds ratio with 95% CI. P value < 0.05 was considered as significant.

resultsA total of 12 studies were included. Probiotic intake was associated with a significantly improved quality of life score in patients with allergic rhinitis (SMD -1.9 (95% CI -3.62, -0.19); P = 0.03), though there was a high degree of heterogeneity. No improvement in quality of life score was noted in asthmatics. Probiotic intake also improved the following parameters: longer time free from episodes of asthma and rhinitis and decrease in the number of episodes of rhinitis per year. Adverse events were not significant.

conclusionAs the current evidence was generated from few trials with high degree of heterogeneity, routine use of probiotics as an additive on therapy in subjects with allergic airway diseases cannot be recommended.

Indexed as

Quality of LifeDatabases, FactualFemaleHumansHypersensitivityMaleMedical Subject HeadingsProbioticsRhinitis, AllergicRhinitis, Allergic, PerennialRisk Assessment

Identifiers

PMID23956972
PMCPMC3727208
OpenAlexW2096180099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.